#BIC2018 - The #investment opportunities session is opened by David Grainger, Co-Founder Medicxi and C21Med - talking about virtualising #biotech opportunities and challenges #BRC@medicxi@C21med
Jim Huntington, Founder of two companies in the C21Med pipeline, @SuperXPharma and #ZFactor wins @businessweekly@UCamEnterprise Academic Entrepreneur of the Year award - well done @JHuntingtonUCam https://t.co/0fxJLEuYhS
Congrats to @RxCelerate Exec Chairman David Grainger & JNJInnovation’s Richard Mason on their new venture spun out of @medicxi. @C21med is an exciting “ideas factory” for early stage biotechnology. Can’t wait to hear more about the Foundation Institute for 21st Century Medicine. https://t.co/TXjXo1AvKz
Proud to share that @RxCelerate is a finalist in the Cambridge News Business Excellence Awards. Meet the 2018 Cambridge News Business Excellence Awards finalists https://t.co/C8oHhLHErd
Excited to announce the launch of The Foundation Institute, an ‘ideas factory’ to translate the best science into novel drugs candidates and new biotech companies. Co-founded by @medicxi @sciencescanner @richardcmason#dreamteam#medicximilestone https://t.co/NKrQ5afXR5